用于控制药物输送和视网膜疾病的再生疗法的质功能化纳米材料
Razieh Dashti1, Fariba Safaei2, Golfam Sadeghian3
1Department of Nanotechnology, Graduate University of Advanced Technology, Kerman, Iran.
Journal of biomaterials applications
|November 4, 2025
概括
纳米颗粒和系统为治疗退行性视网膜疾病提供了新的希望,因为它可以通过向药物输送和组织再生来实现. 这些先进的方法显示出恢复视力和改善患者生活质量的前景.
科学领域:
- 眼科和再生医学眼科和再生医学
- 纳米技术和生物材料
背景情况:
- 退行性视网膜疾病导致不可逆转的视力丧失,传统疗法的成功程度有限.
- 复杂的视网膜结构和血视网膜屏障 (BRBs) 阻碍了有效的治疗.
- 纳米化学和基于的系统提供了精确和生物特异性的方法.
研究的目的:
- 审查视网膜神经再生纳米结构的化学设计和合成.
- 探索生物医学应用,包括向药物输送,组织工程和细胞修复.
- 讨论纳米医学在治疗视网膜疾病方面的进展.
主要方法:
- 对可生物降解的聚合物纳米粒子,脂质体和混合纳米结构的审查.
- 对PEGylation进行分析,以改善稳定性和降低免疫反应.
- 对细胞向和细胞外矩阵 (ECM) 仿真的化功能化的检查.
主要成果:
- 纳米颗粒和联体显示了跨越BRB和控制药物释放的潜力.
- 质功能化的平台增强干细胞分化和神经保护.
- 临床前研究表明,在视网膜再生的动物模型中显示出有希望的疗效.
结论:
- 纳米化学和系统在视网膜疾病治疗方面具有变革性的潜力.
- 解决可扩展性,安全性和交付方面的挑战对于临床翻译至关重要.
- 下一代技术有望满足视力恢复方面的未满足的临床需求.
相关概念视频
Modified-Release Drug Delivery Systems: Classification
315
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
315
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160


